DOJ lauds Guardant Health’s cooperation in cancer test false claims case
By 
Jeff Dale2024-07-17T20:37:00
California-based cancer testing company Guardant Health agreed to pay more than $945,000 to settle allegations levied by the Department of Justice (DOJ) of violating the False Claims Act and Stark Law.
Guardant will pay nearly $914,000 to settle allegations of the violating the False Claims Act, including more than $600,000 in restitution, according to the company’s settlement agreement. Additionally, the company will pay more than $31,000 in an administrative settlement with the Defense Health Agency, the DOJ announced in a press release Tuesday.
The DOJ acknowledged the company’s voluntary self-disclosure to the Department of Health and Human Services’ Office of the Inspector General, among other remedial measures promptly undertaken in reaching settlement.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefAvantor agrees to pay $5.3M to settle false claims, chemicals reporting violations
Laboratory supply company Avantor agreed to pay $5.3 million to settle allegations, first brought by a whistleblower, that it overcharged four federal agencies and failed to comply with chemical regulations, the Department of Justice said.
-
News BriefKindred hospice agrees to pay $19M in multi-state DOJ false claims case
A multi-state hospice home health provider agreed to pay $19.4 million to settle allegations that it paid kickbacks and knowingly billed federal health programs to treat non-terminally ill patients.
-
ArticleSEC enforcement priorities revert back to basics
Recent pronouncements made by the U.S. Securities and Exchange Commission leadership, alongside the recent overhaul of the SEC Enforcement Manual, collectively signal a back-to-basics enforcement approach that appears beneficial for companies in their dealings with the agency.
More from Regulatory Enforcement
-
ArticleFCA drive to reduce its investigation costs likely to add to compliance burden for smaller firms, warn experts
The U.K. financial regulator’s move towards “impactful deterrence” could see smaller and mid-size firms come increasingly under the spotlight as the watchdog aims to tackle market-wide concerns instead of primarily focusing on large players capable of doing the most harm.
-
ArticleInternational agents take down major site where criminals traded stolen corporate info
A major online site used by cybercriminals to buy and sell information stolen from corporations and individuals worldwide has been shut down by an international enforcement action, the Department of Justice announced.
-
ArticleLuxury brands told to tighten AML compliance as Dutch regulator fines Louis Vuitton
Money laundering is no longer a concern just for financial services and real estate. It is everybody’s business. But are most businesses adequately prepared for tighter AML rules? What does compliance need to know?